Heterogeneous impact of an early IFN beta treatment on disability progression in relapsing remitting MS subgroups with differnt baseline clinical profiles.

Authors: TROJANO M; AMATO MP; AVOLIO C; BERGAMASCHI P; CAVALLA P; COMI G; DURELLI L; FAIANI A; GHEZZI A; GIULIANI G; LUGARESI A; LUS G; MILLEFIORINI E; PAOLICELLI D; PATTI F; PELLEGRINI F; POZZILLI G; SALEMI G; VIANELLO M
Publication year: 2007
Type: eedings
OA Link: http://hdl.handle.net/10447/2008